| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 161 | Preserving agent | EP83307337 | 1983-12-02 | EP0112100A3 | 1986-01-15 | Brunt, Keith Douglas; Higton, Frederick Raymond |
@ A tablet for use in preserving samples of milk for analysis comprises bronopol (2-bromo-2-nitropropane-1,3- diol) and a water-soluble solid organic carboxylic acid, the amount of the organic acid being within the range 0.002-0.07 milli-equivalents per milligram of bronopol. The presence of the organic acid stabilises the bronopol, thereby providing a tablet with an adequate shelf life. Suitable organic acids include citric acid, tartaric acid, malic acid, adipic acid, succinic acid and fumaric acid. |
||||||
| 162 | PRESERVATIVE COMPOSITIONS | EP80901567.0 | 1980-07-11 | EP0032500B1 | 1984-09-26 | BERKE, Philip A.; ROSEN, William E. |
| A biocidal composition containing the product produced by the reaction of glycine or a salt of glycine with formaldehyde is disclosed. The composition effectively inhibits growth of bacteria, yeast and mold in a variety of substances susceptible to microbial contamination. | ||||||
| 163 | Preserving agent | EP83307337.2 | 1983-12-02 | EP0112100A2 | 1984-06-27 | Brunt, Keith Douglas; Higton, Frederick Raymond |
@ A tablet for use in preserving samples of milk for analysis comprises bronopol (2-bromo-2-nitropropane-1,3- diol) and a water-soluble solid organic carboxylic acid, the amount of the organic acid being within the range 0.002-0.07 milli-equivalents per milligram of bronopol. The presence of the organic acid stabilises the bronopol, thereby providing a tablet with an adequate shelf life. Suitable organic acids include citric acid, tartaric acid, malic acid, adipic acid, succinic acid and fumaric acid. |
||||||
| 164 | Process for preserving aqueous solutions of milk powder or milk substitute fodder | EP82103033 | 1982-04-08 | EP0063324A3 | 1984-02-08 | LUCK, ERICH, DR.; REMMERT, KARLHEINZ; SEMMIG, ROLF, DR. |
| 165 | PRESERVATIVE COMPOSITIONS | EP80901567.0 | 1980-07-11 | EP0032500A1 | 1981-07-29 | BERKE, Philip A.; ROSEN, William E. |
| Une composition biocide contenant le produit obtenu par la reaction de la glycine ou d'un sel de glycine avec du formaldehyde. La composition inhibe de maniere efficace le developpement de bacteries, levure et moisissures dans une variete de substances susceptibles de contamination microbienne. | ||||||
| 166 | Highly functional cellulose composite | US14237688 | 2012-08-10 | US10080371B2 | 2018-09-25 | Kouichirou Enatsu; Haruko Obata; Naoaki Yamasaki |
| A cellulose composite which contains a cellulose and a polysaccharide and which is characterized in that the median diameter of colloidal cellulose composites contained in the cellulose composite is 0.85 μm or more as measured by a dynamic light scattering method. | ||||||
| 167 | Photodegradation resistant beverage | US14004241 | 2012-03-09 | US09814248B2 | 2017-11-14 | Ippei Ogawa; Takeshi Imazawa; Yumiko Yoshimura |
| The present invention relates to a beverage having excellent photodegradation resistance. More particularly, the present invention relates to a photodegradation resistant beverage comprising a fat-free milk solid content and fat content, the fat content comprising not less than 70% by mass vegetable fat and oil, and the vegetable fat and oil is selected from the group consisting of coconut oil, sunflower oil and a mixture thereof. | ||||||
| 168 | IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL | US15504616 | 2015-08-20 | US20170232038A1 | 2017-08-17 | Vincent O'FLAHERTY; Paul MC CAY |
| The invention is concerned with a pharmaceutical and industrial iodophor preparation, its synthesis and potential applications. The compound has predictable antimicrobial activities. Furthermore, this iodophor is much more stable in the presence of organic material than traditional iodophors. The compositions release free iodine when in solution, which provides the antimicrobial activity. | ||||||
| 169 | HIGHLY FUNCTIONAL CELLULOSE COMPOSITE | US15351749 | 2016-11-15 | US20170055540A1 | 2017-03-02 | Kouichirou ENATSU; Haruko OBATA; Naoaki YAMASAKI |
| A method for producing a cellulose composite containing cellulose and a polysaccharide, wherein a median size of colloidal cellulose composites contained in the cellulose composite as measured by a dynamic light scattering method is 0.85 μm or more, the method including treating a mixture containing cellulose, a polysaccharide and an aqueous medium together in a wet process, wherein a solid content is controlled to be 35 mass % or more, and temperature is set at 80° C. or less. | ||||||
| 170 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | US14514718 | 2014-10-15 | US09404129B2 | 2016-08-02 | Michael Katz; Hans Peter Smits; Jochen Forster; Jens Bredel Nielsen |
| A recombinant micro-organism producing resveratrol by a pathway in which phenylalanine ammonia lyase (PAL) produces trans-cinnamic acid from phenylalanine, cinnamate 4-hydroxylase (C4H) produces 4-coumaric acid from said trans-cinnamic acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA, or in which L-phenylalanine- or tyrosine-ammonia lyase (PAL/TAL) produces 4-coumaric acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA. The micro-organism may be a yeast, fungus or bacterium including Saccharomyces cerevisiae, E. coli, Lactococcus lactis, Aspergillus niger, or Aspergillus oryzae. | ||||||
| 171 | Methods for passive immunization | US13930941 | 2013-06-28 | US09259440B2 | 2016-02-16 | Kirsten Bisgaard-Frantzen |
| The present invention relates to products and methods for preventing, ameliorating and/or treating infections and other diseases. In one aspect, the products of the present invention relates to compositions comprising germ free colostrum. In another aspect, the products of the present invention relates to compositions comprising synthetically multimerized immunoglobulins. In a third aspect, the products of the present invention relates to compositions comprising germ free colostrum enriched with synthetically multimerized immunoglobulins. The invention also relates to use of said compostions as a pharmaceutical e.g. for prophylactic or ameliorating treatment of infections and other diseases. In addition the invention comprises methods for production of said compositions. | ||||||
| 172 | Use of a composition comprising an antimicrobial peptide as a food preservativeuse of a composition comprising an antimicrobial peptide as a food preservative | US13879162 | 2011-10-12 | US09095166B2 | 2015-08-04 | Sara Alexandra Valadas Da Silva Monteiro; Ricardo Manuel De Seixas Boavida Ferreira; Alexandra Manuela Lourenço Carreira |
| The inventors provide the use of a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof to prevent or inhibit spoilage of a foodstuff by a microorganism. Also provided is a method of preventing or inhibiting spoilage of a foodstuff by a microorganism comprising administering to a foodstuff in need thereof an effective amount of a composition comprising an antimicrobial polypeptide comprising Blad or an active variant thereof. | ||||||
| 173 | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof | US12081571 | 2008-04-17 | US09040269B2 | 2015-05-26 | Michael Katz; Hans Peter Smits; Jochen Förster; Jens Bredal Nielsen |
| A recombinant micro-organism producing resveratrol by a pathway in which phenylalanine ammonia lyase (PAL) produces trans-cinnamic acid from phenylalanine, cinnamate 4-hydroxylase (C4H) produces 4-coumaric acid from said trans-cinnamic acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA, or in which L-phenylalanine- or tyrosine-ammonia lyase (PAL/TAL) produces 4-coumaric acid, 4-coumarate-CoA ligase (4CL) produces 4-coumaroyl CoA from said 4-coumaric acid, and resveratrol synthase (VST) produces said resveratrol from said 4-coumaroyl CoA. The micro-organism may be a yeast, fungus or bacterium including Saccharomyces cerevisiae, E. coli, Lactococcus lactis, Aspergillus niger, or Aspergillus oryzae. | ||||||
| 174 | BACTERIALLY FORMED MICROCIN S, A NEW ANTIMICROBIAL PEPTIDE, EFFECTIVE AGAINST PATHOGENIC MICROORGANISMS, E.G. ENTEROHEMORRHAGIC ESCHERICHIA COLI (EHEC) | US14238370 | 2012-08-13 | US20140314830A1 | 2014-10-23 | Florian Gunzer; Anke Zschuettig; Kurt Zimmermann |
| The present invention relates to a new isolated polypeptide nominated microcin S, isolated nucleic acid molecules encoding the microcin S polypeptide and primers and probes hybridizing to the nucleic acid molecules. The invention also relates to plasmids and cells comprising the nucleic acid molecules, an antibody binding to the polypeptide, compositions as well as methods for producing and using the polypeptides. The present invention further relates to medical uses for treating or preventing microbial infections, functional gastrointestinal disorders or treating a tumor. The invention further relates to a method for preserving food and a method for coating dressing material. | ||||||
| 175 | SHELF-STABLE FOOD PRODUCTS AND METHODS OF MAKING SAME | US14008215 | 2012-03-30 | US20140017383A1 | 2014-01-16 | Françoise Pratbernou; François Colomban; Jean-Marc Philippe; Jean-François Bâ; Benoît Fuhrmann |
| The present disclosure relates to packaged long shelf life edible products, in particular dairy products, comprising tamarind extract, neb neb extract and weak organic acids. These packaged long shelf life edible products can be stored during at least 12 months under conditions of high temperature and high humidity level. The present disclosure also describes the manufacturing process for making the same. | ||||||
| 176 | Dairy composition with probiotics and anti-microbial system | US13709334 | 2012-12-10 | US08617625B2 | 2013-12-31 | Gary Francis Smith; Alice Shen Cha; Zuoxing Zheng; Michael Gerard Roman; Benjamin Emanuel Dias |
| Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures. | ||||||
| 177 | PRODUCTS AND METHODS TO PREVENT INFECTIONS | US13930941 | 2013-06-28 | US20130287780A1 | 2013-10-31 | Kirsten BISGAARD-FRANTZEN |
| The present invention relates to products and methods for preventing, ameliorating and/or treating infections and other diseases. In one aspect, the products of the present invention relates to compositions comprising germ free colostrum. In another aspect, the products of the present invention relates to compositions comprising synthetically multimerised immunoglobulins. In a third aspect, the products of the present invention relates to compositions comprising germ free colostrum enriched with synthetically multimerised immunoglobulins. The invention also relates to use of said compostions as a pharmaceutical e.g. for prophylactic or ameliorating treatment of infections and other diseases. In addition the invention comprises methods for production of said compositions. | ||||||
| 178 | Products and methods to prevent infections | US12863745 | 2009-01-22 | US08475789B2 | 2013-07-02 | Kirsten Bisgaard-Frantzen |
| The present invention relates to products and methods for preventing, ameliorating and/or treating infections and other diseases. In one aspect, the products of the present invention relates to compositions comprising germ free colostrum. In another aspect, the products of the present invention relates to compositions comprising synthetically multimerised immunoglobulins. In a third aspect, the products of the present invention relates to compositions comprising germ free colostrum enriched with synthetically multimerised immunoglobulins. The invention also relates to use of said compositions as a pharmaceutical e.g. for prophylactic or ameliorating treatment of infections and other diseases. In addition the invention comprises methods for production of said compositions. | ||||||
| 179 | Dairy Composition With Probiotics And Anti-Microbial System | US13709334 | 2012-12-10 | US20130164410A1 | 2013-06-27 | Gary Francis Smith; Alice Shen Cha; Zuoxing Zheng; Michael Gerard Roman; Benjamin Emanuel Dias |
| Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures. | ||||||
| 180 | PURIFIED PYRROLOQUINOLINE QUINONE FORTIFIED FOOD | US13308279 | 2011-11-30 | US20120070866A1 | 2012-03-22 | Jianxin Gu; Xiaojing Yun; Xiaoning Chen; Si Zhang; Junwu Yang; Yihong Wu |
| Food products fortified by purified PQQ and methods of application and production are disclosed. A method of preserving a food product comprising admixing an effective amount of purified PQQ or a compound containing purified PQQ derivatives with a foodstuff to provide an inhibiting means to microorganism growth in the food product. | ||||||
QQ群二维码
意见反馈
意见反馈